Literature DB >> 12852860

Retroviral genomic RNAs are transported to the plasma membrane by endosomal vesicles.

Eugenia Basyuk1, Thierry Galli, Marylène Mougel, Jean-Marie Blanchard, Marc Sitbon, Edouard Bertrand.   

Abstract

The viral genomes of alpha- and gamma-retroviruses follow an outbound route through the cytoplasm before assembling with the budding particle at the plasma membrane. We show here that murine leukemia virus (MLV) RNAs are transported on lysosomes and transferrin-positive endosomes. Transport on transferrin-positive vesicles requires both Gag and Env polyproteins. In the presence of Env, Gag is rerouted from lysosomes to transferrin-positive endosomes, and virion production becomes highly sensitive to drugs poisoning vesicular and endosomal traffic. Vesicular transport of the RNA does not require prior endocytosis, indicating that it is recruited directly from the cytosol. Viral prebudding complexes containing Env, Gag, and retroviral RNAs are thus formed on endosomes, and subsequently routed to the plasma membrane. This may allow retroviruses to hijack the endosomal machinery as part of their biosynthetic pathway. More generally, tethering to vesicles may provide an efficient mechanism for directed RNA transport.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12852860     DOI: 10.1016/s1534-5807(03)00188-6

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  70 in total

1.  Interaction of Moloney murine leukemia virus matrix protein with IQGAP.

Authors:  Juliana Leung; Andrew Yueh; Frank S K Appah; Bing Yuan; Kenia de los Santos; Stephen P Goff
Journal:  EMBO J       Date:  2006-04-20       Impact factor: 11.598

2.  Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.

Authors:  Virginie Sandrin; Delphine Muriaux; Jean-Luc Darlix; François-Loïc Cosset
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

3.  Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative.

Authors:  Barbara Müller; Jessica Daecke; Oliver T Fackler; Matthias T Dittmar; Hanswalter Zentgraf; Hans-Georg Kräusslich
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

Review 4.  Imaging gene expression in single living cells.

Authors:  Yaron Shav-Tal; Robert H Singer; Xavier Darzacq
Journal:  Nat Rev Mol Cell Biol       Date:  2004-10       Impact factor: 94.444

5.  The cellular HIV-1 Rev cofactor hRIP is required for viral replication.

Authors:  Zhong Yu; Nuria Sánchez-Velar; Irina E Catrina; Ellen L W Kittler; Enyeneama B Udofia; Maria L Zapp
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-04       Impact factor: 11.205

6.  Virus-like particles of the Ty3 retrotransposon assemble in association with P-body components.

Authors:  Nadejda Beliakova-Bethell; Carla Beckham; Thomas H Giddings; Mark Winey; Roy Parker; Suzanne Sandmeyer
Journal:  RNA       Date:  2006-01       Impact factor: 4.942

7.  Visualization of retrovirus budding with correlated light and electron microscopy.

Authors:  Daniel R Larson; Marc C Johnson; Watt W Webb; Volker M Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-17       Impact factor: 11.205

8.  Retrovirus infection strongly enhances scrapie infectivity release in cell culture.

Authors:  Pascal Leblanc; Sandrine Alais; Isabel Porto-Carreiro; Sylvain Lehmann; Jacques Grassi; Graça Raposo; Jean Luc Darlix
Journal:  EMBO J       Date:  2006-05-25       Impact factor: 11.598

9.  Ty3 nucleocapsid controls localization of particle assembly.

Authors:  Liza S Z Larsen; Nadejda Beliakova-Bethell; Virginia Bilanchone; Min Zhang; Anne Lamsa; Rhonda Dasilva; G Wesley Hatfield; Kunio Nagashima; Suzanne Sandmeyer
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

10.  P-body components are required for Ty1 retrotransposition during assembly of retrotransposition-competent virus-like particles.

Authors:  Mary Ann Checkley; Kunio Nagashima; Stephen J Lockett; Katherine M Nyswaner; David J Garfinkel
Journal:  Mol Cell Biol       Date:  2009-11-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.